{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:23:02Z","timestamp":1792120982311,"version":"4.4.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00114","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:08:31Z","timestamp":1583406511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol"],"prefix":"10.3389","volume":"11","author":[{"given":"Patrycja","family":"Bielawiec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br J Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","article-title":"Phytocannabinoids as novel therapeutic agents in CNS disorders","volume":"133","author":"Hill","year":"2012","journal-title":"Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/112_0505","article-title":"Endocannabinoids: synthesis and degradation","volume":"160","author":"Di Marzo","year":"2006","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prostaglandins.2008.12.002","article-title":"Biology of endocannabinoid synthesis system","volume":"89","author":"Wang","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E298","DOI":"10.1007\/BF02854900","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","article-title":"The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease","volume":"26","author":"Mazier","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S1098-3597(06)80041-4","article-title":"The endocannabinoid system: body weight and metabolic regulation","volume":"8","author":"Engeli","year":"2007","journal-title":"Clin Cornerstone"},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1196\/annals.1432.037","article-title":"Ultrastructural localization of neuronal brain CB2 cannabinoid receptors","volume":"1139","author":"Brusco","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/can.2018.0045","article-title":"Theoretical explanation for reduced body mass index and obesity rates in cannabis users","volume":"3","author":"Clark","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11081956","article-title":"Lifestyle and metabolic syndrome: contribution of the endocannabinoidome","volume":"11","author":"Di Marzo","year":"2019","journal-title":"Nutrients"},{"key":"B16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fphar.2019.00430","article-title":"Modulation of the endocannabinoid system as a potential anticancer strategy","volume":"10","author":"Ramer","year":"2019","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11892-019-1248-9","article-title":"The expanded endocannabinoid system\/endocannabinoidome as a potential target for treating diabetes mellitus","volume":"19","author":"Veilleux","year":"2019","journal-title":"Curr Diab Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov Today"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","article-title":"Modulation of transmitter release via presynaptic cannabinoid receptors","volume":"22","author":"Schlicker","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB 1, non-CB 2 cannabinoid related G-protein-coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-642-24716-3_12","article-title":"Sensing of glucose in the brain","volume":"209","author":"Thorens","year":"2012","journal-title":"Handb Exp Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","article-title":"Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation","volume":"204","author":"De Petrocellis","year":"2012","journal-title":"Acta Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid ligands targeting TRP channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.phymed.2009.02.013","article-title":"Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes","volume":"16","author":"Gallant","year":"2009","journal-title":"Phytomedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0144270","DOI":"10.1371\/journal.pone.0144270","article-title":"Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with \u03949-tetrahydrocannabinol","volume":"10","author":"Cluny","year":"2015","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s00125-008-1048-2","article-title":"The endocannabinoid system in obesity and type 2 diabetes","volume":"51","author":"Di Marzo","year":"2008","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? a systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/bph.13000","article-title":"The phytocannabinoid, \u03b49-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects","volume":"172","author":"Cascio","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1038\/nutd.2013.9","article-title":"The cannabinoid \u03949-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity","volume":"3","author":"Wargent","year":"2013","journal-title":"Nutr Diabetes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","article-title":"Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis","volume":"62","author":"Silvestri","year":"2015","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dc16-0650","article-title":"Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel group pilot study","volume":"39","author":"Jadoon","year":"2016","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1039\/CT8966900539","article-title":"XL.\u2014Charas. the resin of Indian hemp","volume":"69","author":"Wood","year":"1896","journal-title":"J Chem Soc Trans"},{"key":"B39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpls.2016.00019","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front Plant Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00213-012-2697-x","article-title":"Cannabinol and cannabidiol exert opposing effects on rat feeding patterns","volume":"223","author":"Farrimond","year":"2012","journal-title":"Psychopharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2017.00422","article-title":"An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bph.12321","article-title":"Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism","volume":"170","author":"Hill","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of l-\u03b1-Lysophosphatidylinositol\/GPR55 Mitogen-activated Protein Kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10681-005-1164-8","article-title":"The inheritance of chemical phenotype in cannabis sativa L. (II): cannabigerol predominant plants","volume":"145","author":"De Meijer","year":"2005","journal-title":"Euphytica."},{"key":"B45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acs.jnatprod.5b00949","article-title":"Evolution of the cannabinoid and terpene content during the growth of cannabis sativa plants from different chemotypes","volume":"79","author":"Aizpurua-Olaizola","year":"2016","journal-title":"J Nat Prod"},{"key":"B46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1\u2013CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","article-title":"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicol Teratol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10681-008-9787-1","article-title":"The inheritance of chemical phenotype in cannabis sativa L. (III): variation in cannabichromene proportion","volume":"165","author":"De Meijer","year":"2009","journal-title":"Euphytica."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E1459","DOI":"10.3390\/molecules24081459","article-title":"Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials","volume":"24","author":"Silvestro","year":"2019","journal-title":"Molecules."},{"key":"B53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: a promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2010.12.031","article-title":"Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors","volume":"490","author":"Ignatowska-Jankowska","year":"2011","journal-title":"Neurosci Lett"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2012.01.032","article-title":"Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice","volume":"142","author":"Liu","year":"2012","journal-title":"Gastroenterology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.4049\/jimmunol.1401844","article-title":"Critical role of mast cells and peroxisome proliferator\u2013activated receptor \u03b3 in the induction of myeloid-derived suppressor cells by marijuana cannabidiol in vivo","volume":"194","author":"Hegde","year":"2015","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"95974","DOI":"10.1155\/2007\/95974","article-title":"PPARs, obesity, and inflammation","volume":"2007","author":"Stienstra","year":"2007","journal-title":"PPAR Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/01.ATV.0000191663.12164.77","article-title":"Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes","volume":"26","author":"Blaschke","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1476-5381.2009.00183.x","article-title":"Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding","volume":"158","author":"Izzo","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol - recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"B64","first-page":"487","article-title":"The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and bodyweight in rats fed a high-fat or a free-choice high sugar diet","volume":"65","author":"Wierucka-Rybak","year":"2014","journal-title":"J Physiol Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1476-5381.2008.00107.x","article-title":"Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice","volume":"156","author":"Riedel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","article-title":"CB 1 cannabinoid receptor-mediated modulation of food intake in mice","volume":"145","author":"Wiley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00415-017-8663-0","article-title":"Cannabidiol as a treatment for epilepsy","volume":"264","author":"Pickrell","year":"2017","journal-title":"J Neurol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcph.1387","article-title":"A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential","volume":"59","author":"White","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"key":"B72","doi-asserted-by":"publisher","first-page":"117957351983199","DOI":"10.1177\/1179573519831997","article-title":"Daily practice managing resistant multiple sclerosis spasticity with delta-9-tetrahydrocannabinol: cannabidiol oromucosal spray: a systematic review of observational studies","volume":"11","author":"Akg\u00fcn","year":"2019","journal-title":"J Cent Nerv Syst Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/epi.14670","article-title":"Cannabidiol in patients with lennox-gastaut syndrome: interim analysis of an open-label extension study","volume":"60","author":"Thiele","year":"2019","journal-title":"Epilepsia"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1212\/WNL.0000000000005254","article-title":"Randomized, dose-ranging safety trial of cannabidiol in dravet syndrome","volume":"90","author":"Devinsky","year":"2018","journal-title":"Neurology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","article-title":"Hu M. The epidemiology of obesity: a big picture","volume":"33","author":"Adela","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/can.2016.0014","article-title":"The fat side of the endocannabinoid system: role of endocannabinoids in the adipocyte","volume":"1","author":"Matias","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fimmu.2012.00240","article-title":"Obesity and endoplasmic reticulum (ER) stresses","volume":"3","author":"Tripathi","year":"2012","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0025-7125(16)33621-5","article-title":"Mechanisms and management of obesity","volume":"47","author":"Aldrich","year":"1963","journal-title":"Med Clin North Am."},{"key":"B79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.beem.2008.10.002","article-title":"The role of the endocannabinoid system in lipogenesis and fatty acid metabolism","volume":"23","author":"Vettor","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.drudis.2018.01.029","article-title":"Peripheral modulation of the endocannabinoid system in metabolic disease","volume":"23","author":"Shrestha","year":"2018","journal-title":"Drug Discov Today"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000230691","article-title":"Role of the endocannabinoid system in abdominal obesity and the implications for cardiovascular risk","volume":"114","author":"Rosenson","year":"2009","journal-title":"Cardiology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-011-9167-3","article-title":"Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle","volume":"12","author":"Silvestri","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2005-2679","article-title":"Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia","volume":"91","author":"Matias","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity","volume":"55","author":"Bl\u00fcher","year":"2006","journal-title":"Diabetes"},{"key":"B87","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"C\u00f4t\u00e9","year":"2007","journal-title":"Int J Obes"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12192-015-0653-5","article-title":"Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes","volume":"21","author":"Lu","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"B89","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.metabol.2008.10.009","article-title":"Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients","volume":"58","author":"Sarzani","year":"2009","journal-title":"Metabolism"},{"key":"B90","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11695-018-3517-0","article-title":"Circulating endocannabinoids are reduced following bariatric surgery and associated with improved metabolic homeostasis in humans","volume":"29","author":"Azar","year":"2019","journal-title":"Obes Surg"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e92989","DOI":"10.1172\/jci.insight.92989","article-title":"Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis","volume":"2","author":"Kimberly","year":"2017","journal-title":"JCI Insight"},{"key":"B93","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/oby.21687","article-title":"Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease","volume":"25","author":"Zelber-Sagi","year":"2017","journal-title":"Obesity"},{"key":"B94","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"key":"B95","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/sj.bjp.0705968","article-title":"The cannabinoid CB 1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin","volume":"143","author":"Tucci","year":"2004","journal-title":"Br J Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1152\/ajpregu.00545.2002","article-title":"Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice","volume":"284","author":"Trillou","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1161\/ATVBAHA.108.176362","article-title":"Effect of rimonabant on the high-triglyceride\/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat the ADAGIO-lipids trial","volume":"29","author":"Despr\u00e9s","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-Year experience from the RIO-Europe study","volume":"365","author":"van Gaal","year":"2005","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2337\/dc09-0455","article-title":"Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial","volume":"33","author":"Hollander","year":"2010","journal-title":"Diabetes Care"},{"key":"B100","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pbb.2010.03.012","article-title":"The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?","volume":"95","author":"Bermudez-Silva","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"B101","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1476-5381.2010.00908.x","article-title":"A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents","volume":"161","author":"Cluny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2013","journal-title":"Cell Metab"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.molmet.2016.10.004","article-title":"Targeting the endocannabinoid\/CB1 receptor system for treating obesity in Prader\u2013Willi syndrome","volume":"5","author":"Knani","year":"2016","journal-title":"Mol Metab"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","volume":"23","author":"Dasarathy","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1136\/gutjnl-2012-302789","article-title":"Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease","volume":"62","author":"Croci","year":"2013","journal-title":"Gut"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","article-title":"Liver fat and lipid oxidation in humans","volume":"29","author":"Kotronen","year":"2009","journal-title":"Liver Int"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.biocel.2010.06.002","article-title":"The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment","volume":"42","author":"Andr\u00e9","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","article-title":"Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11010-016-2702-5","article-title":"Cannabidiol promotes browning in 3T3-L1 adipocytes","volume":"416","author":"Parray","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"B114","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00125-007-0890-y","article-title":"Presence of functional cannabinoid receptors in human endocrine pancreas","volume":"51","author":"Berm\u00fadez-Silva","year":"2008","journal-title":"Diabetologia"},{"key":"B115","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell","volume":"39","author":"Juan-Pic\u00f3","year":"2005","journal-title":"Cell Calcium"},{"key":"B116","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08916930500356674","article-title":"Cannabidiol lowers incidence of diabetes in non-obese diabetic mice","volume":"39","author":"Weiss","year":"2006","journal-title":"Autoimmunity"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"H3602","DOI":"10.1152\/ajpheart.00098.2007","article-title":"Cannabidiol, a nonpsychoactive cannabis constituent, protects against myocardial ischemic reperfusion injury","volume":"293","author":"Durst","year":"2007","journal-title":"Am J Physiol Circ Physiol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","article-title":"Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B120","doi-asserted-by":"publisher","first-page":"15645","DOI":"10.1038\/s41598-017-15154-6","article-title":"Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity","volume":"7","author":"Mehrpouya-Bahrami","year":"2017","journal-title":"Sci Rep"},{"key":"B121","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/oby.2007.106","article-title":"Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet","volume":"16","author":"Starowicz","year":"2008","journal-title":"Obesity"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1161\/01.RES.0000262653.84850.8b","article-title":"Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity","volume":"100","author":"Zhang","year":"2007","journal-title":"Circ Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorganic Med Chem"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ptr.6047","article-title":"Time-dependent effect of phytocannabinoid treatments in fat cells","volume":"32","author":"Ramlugon","year":"2018","journal-title":"Phyther Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MOG.0b013e32832e9c41","article-title":"Neural and hormonal regulation of pancreatic secretion","volume":"25","author":"Chandra","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.phymed.2012.02.001","article-title":"Cannabis exposure associated with weight reduction and \u03b2-cell protection in an obese rat model","volume":"19","author":"Levendal","year":"2012","journal-title":"Phytomedicine"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1159\/000430238","article-title":"Myocardial lipid profiling during time course of high fat diet and its relationship to the expression of fatty acid transporters","volume":"37","author":"Harasim","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B128","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:08:33Z","timestamp":1583406513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":128,"alternative-id":["10.3389\/fendo.2020.00114"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00114","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"article-number":"114"}}